Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma

Purpose. Bladder cancer is one of the most common urological malignancies worldwide, and approximately 90% of bladder cancer cases are histologically typed as bladder urothelial carcinoma (BLCA). Exosomes are 30 to 200 nm extracellular vesicles that transport microRNAs, long noncoding RNAs (lncRNAs)...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen Chen, Anquan Shang, Zujun Sun, Yuting Gao, Jingjuan Huang, Yili Ping, Wenjing Chang, Chenzheng Gu, Junjun Sun, Ping Ji, Yi Yuan, Renquan Lu, Dong Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/9038808
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553663680217088
author Chen Chen
Anquan Shang
Zujun Sun
Yuting Gao
Jingjuan Huang
Yili Ping
Wenjing Chang
Chenzheng Gu
Junjun Sun
Ping Ji
Yi Yuan
Renquan Lu
Dong Li
author_facet Chen Chen
Anquan Shang
Zujun Sun
Yuting Gao
Jingjuan Huang
Yili Ping
Wenjing Chang
Chenzheng Gu
Junjun Sun
Ping Ji
Yi Yuan
Renquan Lu
Dong Li
author_sort Chen Chen
collection DOAJ
description Purpose. Bladder cancer is one of the most common urological malignancies worldwide, and approximately 90% of bladder cancer cases are histologically typed as bladder urothelial carcinoma (BLCA). Exosomes are 30 to 200 nm extracellular vesicles that transport microRNAs, long noncoding RNAs (lncRNAs), mRNAs, circular RNAs, and proteins across tissues and through circulation. Urinary exosomes may contain genetic information from tumor cells. Herein, we explored the clinical significance of urinary exosomal lncRNA telomerase RNA component (TERC) levels to provide an urgently needed diagnostic and prognostic biomarker for BLCA. Materials and Methods. In this study, we used RNA-sequencing of samples from four BLCA patients and three healthy controls to identify that TERC was differentially expressed in urinary exosomes. We then used quantitative PCR in different types of clinical samples to validate the biomarker and analyzed results using receiver operating characteristic curves. Results. We found that TERC was significantly upregulated in urinary exosomes from BLCA patients compared with those from healthy controls (P<0.0001). Urinary exosomal TERC showed higher sensitivity (78.65%) and accuracy (77.78%) than existing indicators including nuclear matrix protein-22 and urine cytometry. Using the cut-off value 4.302, the area under the curve for urinary exosomal TERC was 0.836 (95% confidence interval: 0.768–0.891, P<0.0001). Furthermore, this noninvasive assay could distinguish low-grade and high-grade tumors (P=0.0153). Conclusions. TERC is enriched in urinary exosomes from BLCA patients. Urinary exosomal TERC could become a diagnostic and prognostic biomarker for BLCA that allows clinicians to realize noninvasive detection of BLCA.
format Article
id doaj-art-1cd9fb2e9756414d8cb09ab3e1c8d802
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-1cd9fb2e9756414d8cb09ab3e1c8d8022025-02-03T05:53:27ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/9038808Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial CarcinomaChen Chen0Anquan Shang1Zujun Sun2Yuting Gao3Jingjuan Huang4Yili Ping5Wenjing Chang6Chenzheng Gu7Junjun Sun8Ping Ji9Yi Yuan10Renquan Lu11Dong Li12Department of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Clinical LaboratoryDepartment of Laboratory MedicinePurpose. Bladder cancer is one of the most common urological malignancies worldwide, and approximately 90% of bladder cancer cases are histologically typed as bladder urothelial carcinoma (BLCA). Exosomes are 30 to 200 nm extracellular vesicles that transport microRNAs, long noncoding RNAs (lncRNAs), mRNAs, circular RNAs, and proteins across tissues and through circulation. Urinary exosomes may contain genetic information from tumor cells. Herein, we explored the clinical significance of urinary exosomal lncRNA telomerase RNA component (TERC) levels to provide an urgently needed diagnostic and prognostic biomarker for BLCA. Materials and Methods. In this study, we used RNA-sequencing of samples from four BLCA patients and three healthy controls to identify that TERC was differentially expressed in urinary exosomes. We then used quantitative PCR in different types of clinical samples to validate the biomarker and analyzed results using receiver operating characteristic curves. Results. We found that TERC was significantly upregulated in urinary exosomes from BLCA patients compared with those from healthy controls (P<0.0001). Urinary exosomal TERC showed higher sensitivity (78.65%) and accuracy (77.78%) than existing indicators including nuclear matrix protein-22 and urine cytometry. Using the cut-off value 4.302, the area under the curve for urinary exosomal TERC was 0.836 (95% confidence interval: 0.768–0.891, P<0.0001). Furthermore, this noninvasive assay could distinguish low-grade and high-grade tumors (P=0.0153). Conclusions. TERC is enriched in urinary exosomes from BLCA patients. Urinary exosomal TERC could become a diagnostic and prognostic biomarker for BLCA that allows clinicians to realize noninvasive detection of BLCA.http://dx.doi.org/10.1155/2022/9038808
spellingShingle Chen Chen
Anquan Shang
Zujun Sun
Yuting Gao
Jingjuan Huang
Yili Ping
Wenjing Chang
Chenzheng Gu
Junjun Sun
Ping Ji
Yi Yuan
Renquan Lu
Dong Li
Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
Journal of Immunology Research
title Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
title_full Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
title_fullStr Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
title_full_unstemmed Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
title_short Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
title_sort urinary exosomal long noncoding rna terc as a noninvasive diagnostic and prognostic biomarker for bladder urothelial carcinoma
url http://dx.doi.org/10.1155/2022/9038808
work_keys_str_mv AT chenchen urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT anquanshang urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT zujunsun urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT yutinggao urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT jingjuanhuang urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT yiliping urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT wenjingchang urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT chenzhenggu urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT junjunsun urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT pingji urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT yiyuan urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT renquanlu urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma
AT dongli urinaryexosomallongnoncodingrnatercasanoninvasivediagnosticandprognosticbiomarkerforbladderurothelialcarcinoma